J.P. Morgan is a global industry leader with more than $13.7 trillion in assets under custody and $5.1 trillion in assets under administration. They provide innovative custody, fund accounting and administration and securities services to the world’s largest institutional investors, alternative asset managers and debt and equity issuers.
They leverage scale and capabilities in more than 90 markets to help clients optimize efficiency, mitigate risk and enhance revenue through a broad range of investor services as well as securities clearance, collateral management and alternative investment services.
As a strategic partner with a long-standing commitment and proven experience, J.P. Morgan takes a consultative approach to working with clients to assess and address their individual needs.
J.P. Morgan is a leader in asset management, investment banking, private banking, treasury and securities services, and commercial banking. Today, the firm serves one of the largest client franchises in the world, including corporations, institutional investors, hedge funds, governments and affluent individuals in more than 100 countries. J.P. Morgan’s core businesses include: Asset Management Investment Bank Private Banking Securities Services Treasury Services Commercial Banking
|Biolex Therapeutics||10/08||Series D||$60M||12|
|EUSA Pharma||6/07||Venture Round||$9.1M||7|
|Reliance Globalcom||6/06||Venture Round||$8.5M||4|
|Tropic Networks||5/05||Series D||$33M||9|
|Reliance Globalcom||4/05||Venture Round||$24M||4|